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A Multi-SNP Locus-Association Method Reveals
a Substantial Fraction of the Missing Heritability
Georg B. Ehret,1,2,8 David Lamparter,3,4,8 Clive J. Hoggart,5,8 Genetic Investigation of Anthropometric
Traits Consortium, John C. Whittaker,6 Jacques S. Beckmann,3,7 and Zolta´n Kutalik3,4,*
There are many known examples of multiple semi-independent associations at individual loci; such associations might arise either
because of true allelic heterogeneity or because of imperfect tagging of an unobserved causal variant. This phenomenon is of great impor-
tance in monogenic traits but has not yet been systematically investigated and quantified in complex-trait genome-wide association
studies (GWASs). Here, we describe a multi-SNP association method that estimates the effect of loci harboring multiple association
signals by usingGWAS summary statistics. Applying themethod to a large anthropometric GWASmeta-analysis (from theGenetic Inves-
tigation of Anthropometric Traits consortium study), we show that for height, bodymass index (BMI), andwaist-to-hip ratio (WHR), 3%,
2%, and 1%, respectively, of additional phenotypic variance can be explained on top of the previously reported 10% (height), 1.5%
(BMI), and 1% (WHR). The method also permitted a substantial increase (by up to 50%) in the number of loci that replicate in
a discovery-validation design. Specifically, we identified 74 loci at which the multi-SNP, a linear combination of SNPs, explains signif-
icantly more variance than does the best individual SNP. A detailed analysis of multi-SNPs shows that most of the additional variability
explained is derived from SNPs that are not in linkage disequilibriumwith the lead SNP, suggesting amajor contribution of allelic hetero-
geneity to the missing heritability.Introduction
Hundreds of genome-wide association studies (GWASs)
have been performed for the identification of common
genetic polymorphisms influencing human traits or pre-
disposing to common diseases.1 It has become clear that
a large number of genetic variants contribute to these
phenotypes and that each individual SNP has a small over-
all effect. In classical GWASs, a list of the most promising
loci is established in a set of discovery studies by the selec-
tion of variants with an association p value below a certain
threshold. For each locus, only one variant (the one with
the strongest association) is kept and tested in an indepen-
dent set of studies for association. When the combined
discovery and validation association p value of a SNP is
below a predefined multiple-testing-controlled threshold
(typically 53 108), the variant is declared to be replicated
and—so that the winner’s curse phenomenon can be
avoided—the explained variance (EV) is estimated on the
basis of the validation effect size.
These EVs can be summed for all replicated markers
for obtaining the total explained variance (TEV), i.e., the
heritability explained by all GWAS hits. The TEV for
almost all traits is markedly smaller than the heritability
estimated by twin or family studies, and this discrepancy
has been termed missing heritability.2,3 Several studies
have examined possible causes of this phenomenon, and
these include (1) many more existing markers with smaller1Division of Cardiology, Geneva University Hospital, Geneva 1211, Switzerland
sity, Baltimore, MD 21205, USA; 3Department of Medical Genetics, University o
Lausanne 1005, Switzerland; 5Department of Pediatrics, Imperial College Lond
age SG1 2NY, UK; 7Service of Medical Genetics, Centre Hospitalier Universitai
8These authors contributed equally to this work
*Correspondence: zoltan.kutalik@unil.ch
http://dx.doi.org/10.1016/j.ajhg.2012.09.013. 2012 by The American Societ
The Americaneffects,4 (2) the effect of (unmeasured) rare variants,5
(3) poor tagging of causal variants,6 and (4) allelic hetero-
geneity.7
In this paper, we address the problem of allelic hetero-
geneity and imperfect tagging with a multi-SNP associa-
tion methodology. This method assumes that a given
phenotype is influenced at each quantitative-trait locus
(QTL) by one or more causal variant(s), whose effect(s)
can be approximated (or tagged) by a linear combination
of multiple semi-independent observed variants at the
locus. This linear combination of SNPs is termed a multi-
SNP. Throughout the manuscript we will use the term
multivariate regression when a single response variable is
(jointly) regressed on multiple explanatory variables (mul-
tiple regression). Note that our approach is blind to the
difference between true allelic heterogeneity and multiple
independent signals tagging a unique unobserved causal
variant. Thus, for simplicity, we use the term allelic hetero-
geneity to describe both scenarios.
By applying our method to the association summary
statistics of height, body mass index (BMI), and waist-to-
hip ratio (WHR) from the GIANT (Genetic Investigation
of Anthropometric Traits) consortium study,8–10 we show
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Material and Methods
Assume that at a given locus, a truly causal variant is associated
with a particular phenotype. As mentioned before, the term causal
variant is used in a general sense and can represent a single
SNP, a haplotype, a copy-number variant, or the combination of
multiple semi-independent variants at one locus, etc. Let g˛Rn
denote the genotype values of this variant in a population sample
of size n, and let y be the observed phenotype values. The effect
size of the variant is bg , i.e., y ¼ bgg þ ε, where ε  Nð0; s2Þ. The ex-
plained variance can simply be calculated as
r2g ¼
b2gVarðgÞ
b2gVarðgÞ þ s2
:
This variant might neither be observed directly nor be in
the imputation reference panel. However, several measured or
imputed variants at the same locus might show association with
the phenotype as a result of linkage disequilibrium (LD) with
the causal variant. Let F˛Rn3m denote the available genotype
data at this locus, i.e., allele dosages for m SNPs. For simplicity,
assume that the phenotype and all genotype vectors are normal-
ized to have a mean of zero and unit variance across individuals.
The explained variance of the m SNPs at the locus can be approx-
imated by
br2 locus ¼ 1 bs2 ¼ 1 RSS
nm;
where bs2 is the unbiased estimate of the residual variance and RSS
is the residual sum of squares, which can be expressed as
¼ 1 1
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First, note that the subtraction of the term m/n guarantees that
the estimate is unbiased; hence, Eð br2 locusÞ ¼ 0 if the locus is not
associated with the phenotype. Second, this partitioning permits
a simple estimation of the explained variance of a locus: with nor-
malized genotype and phenotype data, 1=n FTy ¼ bb is the vector
of estimated marginal effects of the m SNPs at the locus (infor-
mation that will be readily available from meta-analyses) and
1=n ðFuFÞ ¼ C is the SNP correlation matrix, which can be esti-
mated from external data. This partitioning of the formula for
approximating multivariate effect sizes has also been proposed
by Yang et al.11
We show in Supplemental Data section 1 (available online) thatbr2 locus is a lower bound on the EV of the causal variant g, i.e.,
r2gR
br2 locus ¼ n
nm
bbuC1bb m
n

: (Equation 1)
This estimate does not require any information on the causal
variant. To declare a locus association as significant, we have to
consider not only br2 locus but also its variance, which can be shown
to be
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(see Supplemental Data section 2).864 The American Journal of Human Genetics 91, 863–871, NovembFinally, we use br2 locus to (1) test the significance of the multi-
SNP association and (2) compare the TEV of the multi-SNP with
the TEV of the lead SNP only (see Supplemental Data section 3
for details). Once we calculate nominal p values for each locus,
we use a false-discovery-rate (FDR) control to adjust for multiple
testing.12Calculation of the Multi-SNP in Practice
We identify several reasons why we do not include all SNPs at the
given locus in the multi-SNP. (1) Depending on the number of
SNPs at a given locus, C can be rather large, and this results in
a high condition number13 and subsequently introduces signifi-
cant inaccuracy in the calculation of Equation 1. (2) Clearly, it is
not worth including too many nonassociated SNPs in F given
that adding them does little to increase the expectation of br2 locus
but increases its variance (see Equation 2), which increases with
m and hence decreases the power of the multi-SNP method. Simu-
lation results presented in Figure S1C further support this
phenomenon. This problem is akin to the bias-variance tradeoff
and has been extensively studied.14 (3) SNPs in high LD tend to
carry redundant information. (4) The greater the number of
SNPs included at a given locus, the greater the sensitivity of the
EV estimate to the correlation matrix C.
These considerations motivated the removal of SNPs that
showed nonsignificant univariate associations (p > 0.01) and
SNPs in LD (r2 > 0:1) with another marker (with a lower p value).
We demonstrated that the proposed SNP-filtering procedure
results in increased power (Figure S1) and provides EV estimates
robust to the source of the correlation data (see Results).
However, the SNP-selection process introduces a bias in the esti-
mation of the lower-bound value. This bias can be avoided if the
samples are split into discovery and validation subsets. Such parti-
tioning of the data set is analogous to the ‘‘training-test’’ set divi-
sion in cross-validation. However, we emphasize the fact that
our methodology is a natural extension of the classical GWAS
routine, and we therefore keep the discovery-validation termi-
nology. The first set is used for obtaining a relevant subset of
SNPs (i.e., SNPs with a p value < 0.01 and pairwise LD r2 < 0:1)
constituting the multi-SNP, whereas the other data set is then
used for providing unbiased estimates of the effect sizes for the
chosen multi-SNP. As opposed to replicating only the lead SNP,
we carry forward a set of SNPs for each locus into the validation
phase, where we test the multi-SNP by approximating the joint
effect of a locus. The two-step procedure is outlined in Figure 1.In Silico Analysis
To demonstrate the utility of our method in a controlled setting,
we simulated phenotype data by mimicking the imperfect-tagging
scenario. To this end, we fixed a genomic region and randomly
selected an additively coded SNP g and created a phenotype that
was additively associated with this SNP. In formula y ¼ g þ ε,
ε  N ð0;s2Þ with s2 ¼ VarðgÞ$ð1=r2g  1Þ. This ensures that the ex-
plained variance is r2g .
In this region (5500 kb), we then masked all SNPs whose LD
with the causal locus was higher than a certain threshold (r).
The data (n ¼ 5,000 from the CoLaus study; see Supplemental
Data section 9 for further details) were then equally split into
discovery and validation parts. We used the discovery data to
select those unmasked SNPs whose p value was below a predefined
threshold a. We then used the validation data for these SNPs to
estimate the EVof the multi-SNP approximating the causal markerer 2, 2012
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Figure 1. Brief Summary of the Multi-
SNP Locus-Association Method
First, SNPs at the locus were prioritized (on
the basis of their discovery p values) and
were LD pruned (on the basis of their
pairwise LD). The emerging SNPs were
taken to validation, where the multi-SNP
was created as their optimal linear com-
bination and was tested against the chi-
square distribution for obtaining the
multi-SNP association p value.according to Equation 1. This estimate was then contrasted with
the EV estimate of the top associated observed SNP. This exercise
was carried out for various genomic regions, masking thresholds
(r), strengths of causal association (r2g ), and SNP-selection thresh-
olds (a). For each parameter setup, the phenotype was simulated
1,000 times, and the results were averaged over these repeats.Application to Meta-analysis Summary Statistics
To apply our multi-SNP association method to the association
summary statistics of the GIANT consortium (for height,8 BMI,9The American Journal of Human Genand WHR10), we split the studies into
two groups of cohorts (total sample
size ¼ 81,000 and 47,000) and meta-
analyzed each group of studies separately.
Note that for further validation purposes,
we did not include the CoLaus15 cohort
in this meta-analysis. The first group of
studies served as discovery samples, and
the second group served as validation
samples. Loci were defined as the 50.5
cM region around each lead SNP. Lead
SNPs were selected on the basis of their
discovery p values (p < 102) and were
subsequently pruned such that neigh-
boring lead SNPs were forced to be at least
1 cM apart. Note that by definition, the
loci do not overlap, which ensured count-
ing each signal only once. Subsequently, at
each locus, SNPs below a certain p value
threshold (p < 102) were pruned such
that if two SNPs were in LD (r2 > 0:1),
the one with a less significant p value (in
the discovery cohort) was thrown away.
For each locus, we estimated the effect
size in the validation sample for the
selected set of semi-independent SNPs.
Finally, we again used the estimate of
the correlation matrix (external genotype
data) to obtain a lower bound on the EV
at each locus.
Results
In Silico Results
First, we simulated a scenario in
which a causal variant is imperfectly
tagged by masking all SNPs whoseLD with the causal marker was higher than a certain
threshold. Second, we applied both the standard single-
SNP method and our multi-SNP method to estimate the
EV of the underlying causal marker.
Figure 2A illustrates how the EV of the multi-SNP
increases as a function of increasing discovery p value
threshold a (without LD pruning). For completeness, we
also explored a wide range of p-value- and pruning-
threshold combinations for a fixed simulation scenario
(see Supplemental Data section 8) and observed largeetics 91, 863–871, November 2, 2012 865
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Figure 2. Properties of the Variance Ex-
plained by Multi-SNPs
(A) The multi-SNP was generated for
various EV values and SNP-selection
thresholds (a), whereas all SNPs with an
LD r2R0:5 with the casual variant were
set unobserved.
(B) The multi-SNP was computed for
various EV values (r2g ) and for maximal
LD (r2) between the observed SNPs and
the causal variant. Here and for the rest
of the experiment, we fixed a at 2 3 102.
(C) The EV of the multi-SNP is plotted
against that of the best associated observed
SNP. The estimates were again generated
for various EV values (r2g ) and for maximal
LD (r2) between the tagged SNPs and the
causal variant. The dotted black line indi-
cates a ten-fold increase.
(D) LD (squared correlation) between the
causal SNP and the derived multi-SNP
(dashed line) and top associated SNP (solid
line). The color coding for (C) and (D)
agrees with that of (B).variations in statistical power. Because the optimal combi-
nation is, in reality, not known, we deliberately chose
a nonoptimal strategy of a ¼ 2 3 102 combined with
no LD pruning for the rest of the simulation experi-
ment. Second, we noticed that the EV of the true causal
marker was remarkably well estimated even when many
LD friends (r2 > 0:2) of the causal SNP were masked
(Figure 2B). Third, in such poor tagging scenarios, single
(lead)-SNP associations yielded ten times smaller EVs
than did multi-SNPs (Figure 2C). Finally, associated
multi-SNPs were much more closely linked to the causal
variant than were top associated single SNPs. In Fig-
ure 2D, we plotted the LD (squared correlation) between
the causal variant and the multi-SNP, as well as the LD
between the causal variant and the best associated SNP
(in the discovery sample). These results demonstrate that
our multi-SNP-association method offers a substantial
benefit over single-SNP associations in the case of imper-
fect tagging.
Application to GIANT Association Summary Statistics
We then tested the multi-SNP method by using the associ-
ation summary statistics of the GIANT consortium for
height,8 BMI,9 and WHR adjusted for BMI.10 In order to
have both discovery and validation summary statistics
for every SNP genome-wide, we partitioned the discovery
studies into two groups before meta-analyzing them sepa-
rately. These two groups represent the discovery and vali-
dation samples for the purpose of this paper. We then
selected SNPs on the basis of discovery univariate p values
and pairwise LD. Then, we combined these SNPs together866 The American Journal of Human Genetics 91, 863–871, November 2, 2012into a multi-SNP via a multivariate
linear regression in the validation
sample. Finally, we tested how much
phenotypic variance was explainedby the multi-SNP and compared this EV to the one ex-
plained by single-SNP analysis.
For height, we detected 2,073 loci with a lead-SNP
p value < 0.01 in the discovery panel. Because the EV
estimates were unbiased and independent (Figures S5
and S6), we could simply sum up the estimates for all
2,073 selected height loci and determine the total fraction
of EV. We also calculated the EV by only using the lead
SNP from each locus (‘‘single-SNP’’ analysis). A striking
difference was observed between the two estimates (see
Table 1): for height, single-SNP associations explained
6.9% of phenotypic variance, whereas the multi-SNPs at
the same loci explained 13.5%. Differences for BMI and
WHR were slightly less pronounced: single-SNP associa-
tions explained 2% and 0.1% of the variance for BMI and
WHR, respectively, whereas multi-SNP associations ex-
plained 3.6% and 2.2% of the variance for BMI and
WHR, respectively, at a locus-selection p value < 0.01.
These findings suggest that a non-negligible fraction of
the missing heritability—at least for the traits examined
in this paper—might be due to multiple independent
effects per locus. Note that even if only half of the sample
size is used for confirming associations, the multi-SNP
method explains more variance than does using the entire
sample with just a single-SNP analysis.
To further demonstrate that our methodology is not
biased and also that EV estimates from different loci can
be simply summed up, we calculated how much pheno-
typic variance was explained by all the derived multi-
SNPs in the independent CoLaus study,15 which was not
used in either the discovery or the replication samples.
Table 1. TEV of Single SNPs and Multi-SNPs for Each Anthropometric-Trait Phenotype
Trait p Value Number of Loci (FDR)
TEV Number of Replicated Loci
Single SNP Multi-SNP Single SNP Multi-SNP
Height p < 5 3 108 106 (0.0%) 4.10% 6.93% 93 96
p < 1 3 102 2,073 (80.0%) 6.88% 13.52% 142 186
BMI p < 5 3 108 18 (7.0%) 0.92% 1.02% 15 16
p < 1 3 102 2,031 (95.0%) 1.96% 3.61% 15 25
WHR p < 5 3 108 2 (0.0%) 0.09% 0.09% 2 2
p < 1 3 102 1,985 (100.0%) 0.12% 2.22% 0 2
These estimates account for the number of SNPs constituting the multi-SNP association. FDR was estimated with the Bayes’ theorem (for details, see Supplemental
Data section 4). The following abbreviations are used: FDR, false discovery rate; TEV, total explained variance; BMI, body mass index; and WHR, waist-to-hip ratio.Each multi-SNP is a linear combination of its constituting
SNPs, and the coefficients are determined on the basis of
the replication summary statistics and the SNP correlation
matrix (obtained from external cohorts). Knowing these
coefficients, we constructed all the multi-SNPs in the
CoLaus sample. We then regressed height simultaneously
on the 2,073 height-related multi-SNPs and calculated
the EV adjusted for the number of variables.16 We repeated
the same exercise for BMI and WHR. The estimates for
height and BMI agreed well with those obtained by our
method, although the 95% confidence intervals (CIs)
were wide because of the relatively small size of the CoLaus
sample: 13.2% (CI 10.1%–16.3%) versus 13.5 for height,
2.3% (CI 0.9%–5.6%) versus 3.6 for BMI, and 0.2%
(CI 3.4%–3.0%) versus 2.2% for WHR.
For BMI, only loci with small lead-SNP effects harbored
allelic heterogeneity, whereas for height, these loci were
distributed evenly across the whole spectrum of discovery
lead-SNP p values (5 3 108 to 5 3 102) (Figure 3).
Next, we applied a Benjamini-Hochberg FDR control
for the validation p values. For the 2,073 loci, 142 lead
SNPs replicated at 5% FDR, whereas 186 multi-SNPs were
confirmed at the same FDR. BMI and WHR showed a
similar advantage with the use of multi-SNP association
(see Table 1).
To establish an inventory of loci with significant evi-
dence of potential allelic heterogeneity, we formally tested
whether themulti-SNP explains more phenotypic variance
than the best individual SNP in the region. The chi-square
test we applied here takes into account the number of
SNPs that the multi-SNP was created from. For height,
BMI, and WHR, 65, 7, and 2 loci, respectively, were clas-
sified as exhibiting significant allelic heterogeneity. A
detailed list of such loci can be found in Table S4. Here,
we only show one example for height association at the
15q26.1 locus (Figure 4).
Given that we were able to estimate the weights assigned
to the SNPs that constitute the multi-SNP, we could con-
struct the multi-SNP genotype by using the genotype
data of its scaffold SNPs and thus calculate the LD
between the multi-SNP and the surrounding SNPs in the
region. Figure 4 shows the LD in the region and enablesThe Americanthe composite signal of the multi-SNP to be visualized.
As can be observed, the association signal is rather broad
(top panel); however, not all the signals are due to LD
with the lead SNP (middle panel). The multi-SNP encom-
passes these independent associations and explains most
of the observed association in the region (bottom panel).
Interestingly, the multi-SNP, unlike the lead SNP, is in
strong LD with several missense variants in ACAN (MIM
155760). Not surprisingly, the SNPs picked up by the
multi-SNP are predicted to be benign by PolyPhen.17 Also,
a recent Korean exome-sequencing study found a height-
associated, nonsynonymous SNP in ACAN.18 These obser-
vations suggest that we are indeed observing the effect of
multiple causal variants.
Application to Lipid Association Summary Statistics
In addition to the anthropometric trait associations, we
also tested our method on triglyceride, high-density-lipid,
low-density-lipid, and total-cholesterol association sum-
mary statistics of the largest-to-date lipid meta-analysis
study.19 Given that we had no access to separate discovery
and validation summary statistics in the lipid meta-anal-
ysis, we had to adapt our method in order to obtain
unbiased estimates for the difference in TEV between
single and multi-SNP associations. We chose an approach
that is conservative (see Material and Methods). Neverthe-
less, we were still able to detect a 10%–25% relative in-
crease in TEV for these traits when we usedmulti-SNP asso-
ciation. Additional results are provided in Supplemental
Data section 10.
Robustness
Because themeta-analyses report only univariate SNP asso-
ciations, we derived multivariate effects by using external
data to estimate the LD structure of the selected SNPs at
each locus. Given that the LD structure can have a great
impact on our results, we compared the EV across six
different external studies. These cohorts are of individuals
from a diverse spectrum of European ancestry and were
genotyped on various platforms (Figure S3). For each locus,
the different EV estimates, obtained from the six different
LD estimates used in our method, were compared to eachJournal of Human Genetics 91, 863–871, November 2, 2012 867
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Figure 3. Gain in the TEV for Height
and BMI
The TEV of single SNPs and multi-SNPs is
plotted as a function of the discovery-p-
value cutoff. Although pronounced allelic
heterogeneity can be observed throughout
the whole p value spectrum for height (A),
only SNPs with a smaller effect tend to
harbor significant multi-SNPs for BMI (B).other. This comparison showed only a 5% median coeffi-
cient of variation (CV) in the EV estimates across the six
LD patterns, which demonstrates that our methodology
is robust to moderate deviations in the LD structure. Sensi-
tivity analyses showed that less stringent LD pruning
thresholds (r2 > 0:3 and r2 > 0:5) increased the CV (8%
and 10%, respectively).Discussion
We have developed a methodology that is able to estimate
the lower bound of the TEV at a locus, and we show that
this is significantly larger than the variance explained by
the best SNP at the locus. The method exploits imperfect
tagging and allelic heterogeneity. The estimate relies on
the univariate effect-size estimates and sample sizes for
each available SNP and the correlation structure of the
SNPs at the given locus. The estimate can also be interpreted
as the EV of the association between a multi-SNP and the
particular phenotype. The multi-SNP is a specific linear
combination of some measured SNPs at the given locus
and enables us to better resolve the association signal.
In silico simulations showed that this approach can
better detect causal markers in imperfect-tagging scenarios.
Furthermore, we have demonstrated that additional prun-
ing facilitates its application to large meta-analytic studies.
We also applied this tool to the meta-analysis summary
statistics obtained from the GIANT consortium. The anal-
ysis yielded many associated loci and significantly in-
creased the TEV.
A recent paper identified substantial allelic heteroge-
neity at expression QTLs.20 Also, for autoimmune diseases,
the major-histocompatibility-complex region has revealed
multiple independent effects.21–23 The GIANT height
paper8 looked at secondary associations and distinguished
19 loci in which more than one SNP seemed to influence
the phenotype. Remarkably, 11 out of these 19 loci were
also among our list of 65 height loci. The nonreplicating
loci could be due to insufficient power (because of the
halved sample size) or to having too many SNPs included
in the multi-SNP in cases where the signal was mainly
driven by just two or three SNPs.868 The American Journal of Human Genetics 91, 863–871, November 2, 2012A region-based meta-analysis was
proposed for the study of individuals
deriving from different ethnic groups,
and the authors of this study high-lighted the need to consider more than just individual
SNP associations.24 Their method also encompassed asso-
ciation information across multiple SNPs at a given locus,
and significance was assessed by a binomial test. Their
method has a different focus of application, and hence is
not designed to estimate EV, cannot use meta-analysis
summary statistics, does not estimate exact signal localiza-
tion, and is indifferent to the actual SNPs’ contribution to
the combined association signal.
While our work was under review, an independent study
also proposed a methodology for addressing conditional
and joint SNP analysis in the GWAS framework.11 They
also used an external reference sample to derive the LD
structure in order to approximate multivariate regression
when only univariate summary statistics are given. The
authors also used the GIANT summary statistics to demon-
strate the utility of their method. There are important
differences between their method and ours: (1) We used
discovery and validation samples to derive unbiased esti-
mates for the EV of the multi-SNP. Their proposed method
used the complete sample and applied a very stringent
(genome-wide significant) p value threshold for SNP selec-
tion to avoid the winner’s curse phenomenon. (2)Whereas
we filtered SNPs on the basis of their marginal association p
values and pairwise LD, Yang et al. used an elegant stepwise
procedure for SNP selection, but without replication, they
could not fully exclude any bias in their estimates. (3)
Because we used an independent replication sample, we
could apply a less stringent p value threshold and could
thus examine many more loci without being restrained
by a winner’s curse. The use of an independent replication
sample enabled us to calculate an unbiased estimate of the
TEV of the model proposed in the discovery stage regard-
less of the number of false-positive SNPs included in the
multi-SNP. We chose to select SNPs on the basis of LD-
pruned marginal association p values and accepted that
some of them might turn out to be false at the validation
stage. Therefore, these two methods are complementary:
our method is more suited to detect weaker associations
with many possible close-to-optimal model configurations
and thus allows for more constituting SNPs, but it is less
tailored to detect scenarios in which the phenotype is
driven by only a few distinct associated SNPs and not by
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Figure 4. Example of a Height-Associated Locus with Strong Allelic Heterogeneity
The top associated variant is in weak LD with all nonsynonymous markers in ACAN. However, the multi-SNP captures these SNPs.many other variants at the locus. When applying our
method to the anthropometric GWASs of the GIANT con-
sortium, we found more significant multi-SNP associations
(n ¼ 65 loci for height) than did the method of Yang et al.
(n ¼ 36 loci for height); these loci explain more pheno-
typic variance (5.3% for our method versus 4.1% for the
Yang et al. method). Importantly, 24 out of their 36 loci
were also found by our method (hypergeometric test, p ¼
1.1 3 1029).
Note that even in large studies, we do not have suffi-
cient statistical power to distinguish between the best
competing multivariate models. The top model emerging
from Yang et al.’s analysis for a given locus is not signifi-
cantly better than many other models containing slightly
different SNPs. Predictors (deterministically) selected from
a set of correlated variables (like SNP data for a locus)
are highly interchangeable. There is little importance of
the actual SNPs selected for the optimal model because
many different models can fit the data similarly well.
This can be easily demonstrated by MCMC sampling of
the model space for any locus with allelic heterogeneity.
For this reason, we put more emphasis on the EV of
the model than on the actual SNPs constituting the
multi-SNP.The AmericanOur methodology cannot distinguish between true alle-
lic heterogeneity andmultiple independent signals tagging
an unobserved variant. We asked, nevertheless, whether
any discovered multi-SNP (composed of HapMap SNPs)
could be tagging a single SNP present only in the 1000
Genomes catalog. This comparison did not identify such
a multi-SNP, indicating that imperfect tagging might be
less of an issue for common-variant associations (Fig-
ure S7). Note, however, that the LD-pruning step in our
procedure slightly reduces the chance of detecting an
imperfect-tagging scenario in set-ups where only associa-
tion summary statistics are available. A similar conclusion
was reached by Yang et al.11
We found that loci with higher marker density are
slightly more prone to harbor allelic heterogeneity (p ¼
0.002; see Table S2). A possible reason for this is that better
coverage enables our methodology to pick up stronger
secondary signals. We also found evidence that more
conserved loci exhibit more allelic heterogeneity (p ¼
2.5 3 104; see Table S3). Although high allelic heteroge-
neity has been linked to low mutation frequency,25 we
did not find a significant difference in minor allele fre-
quency (MAF) between loci with strong versus weak evi-
dence of multiple signals (Student’s t test, p ¼ 0.67). WeJournal of Human Genetics 91, 863–871, November 2, 2012 869
observed, however, that SNPs constituting the confirmed
multi-SNPs (p ¼ 4.66 3 1041) tended to have a lower
MAF (0.17) than expected (0.22).
In some cases, the lead SNP alone might not replicate
because of fluctuations in the p values, but our multi-
SNP approach can be more robust to such variations.
Moreover, using multi-SNP associations could potentially
improve the detection of pleiotropy in case multi-SNPs
associated with different traits at the same locus at least
partially overlap. These instances of pleiotropy would be
missed by a standard single-SNP association framework.
An important application of our methodology can be
to assess the total contribution of variants in specific candi-
date genes (or pathways) in order to prioritize them. This
would be simply done through the restriction of multi-
SNP association to particular genes (or pathways) of in-
terest. A gene-centered GWAS approach was proposed for
the assessment of deviations from the local quantile-quan-
tile plot.26 However, this method does not attempt to
compute cumulative EV and is not applicable to summary
statistics.
Our method is implemented in a MATLAB-package
multi-SNP, and we added a multivariate association option
to our standalone software QUICKTEST.
In summary, our proposed method of investigating
allelic heterogeneity revealed that a substantial fraction
of the missing heritability can be explained by this
phenomenon.Supplemental Data
Supplemental Data include nine figures and eight tables and can
be found with this article online at http://www.cell.com/AJHG.Acknowledgments
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